14.03.2018 • News

BP Licenses PTA Technology to Socar Turkey

BP Licenses PTA Technology to Socar Turkey (c) BP
BP Licenses PTA Technology to Socar Turkey (c) BP

BP is licensing its latest generation purified terephthalic acid (PTA) technology to SOCAR Turkey Enerji. The Turkish company will use the technology for a new 900,000 t/y plant in Aliaga, which is expected to go on stream by 2023, pending a final investment decision.

“This investment is highly strategic for us, fulfilling our intent to create a value chain by integrating our newly-announced aromatics complex adjacent to the Star refinery and Petkim plant in Aliaga with the most competitive PTA technology,” said Emil Eminov, chief operating officer of SOCAR Turkey. “This will create the most competitive asset in Turkey and the Middle East and will serve the high demand for PTA in Turkey and surrounding regions.”

The Star refinery, which is due to be commissioned in September of this year, is reported to include production of 1 million t/y of reformate and mixed xylenes, along with naphtha feedstock for Petkim. SOCAR Turkey, part of Azerbaijan’s energy group SOCAR, acquired Petkim in 2008.

BP said its PTA technology has significantly lower capital and operating costs compared to rival processes. The UK-based group has an alliance with French engineering and construction group Technip for PTA projects, which was extended in December 2016 to include acetic acid.

Interview

Leading Transformation
The Path to Sustainable Growth

Leading Transformation

As Executive Vice President of International Chemicals since early 2024, Antje Gerber has been steering Sasol through a pivotal reset—focused on resilience, innovation, and bold sustainability goals.

Expert Insights

Dual‑Targeting Breakthroughs
Advancements in Bispecific Antibody Development

Dual‑Targeting Breakthroughs

Unlock the latest breakthroughs in bispecific antibody development! Download Wiley’s free Expert Insights eBook to explore cutting-edge dual-targeting strategies, advanced purification methods, and bioanalytical technologies transforming immunotherapy and cancer treatment.

most read

Photo

VCI Welcomes US-EU Customs Deal

The German Chemical Industry Association (VCI) welcomes the fact that Ursula von der Leyen, President of the European Commission, and US President Donald Trump have averted the danger of a trade war for the time being.